Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$255K Sell
54,645
-3,273
-6% -$14.5K ﹤0.01% 2197
2019
Q3
$268K Sell
57,918
-6,605
-10% -$31.6K ﹤0.01% 2104
2019
Q2
$301K Buy
64,523
+319
+0.5% +$1.43K ﹤0.01% 1994
2019
Q1
$276K Sell
64,204
-16,466
-20% -$75.6K ﹤0.01% 2017
2018
Q4
$316K Buy
80,670
+3,804
+5% +$16.2K ﹤0.01% 1742
2018
Q3
$351K Sell
76,866
-1,536
-2% -$7.32K ﹤0.01% 1733
2018
Q2
$363K Sell
78,402
-2,642
-3% -$15.5K 0.01% 1544
2018
Q1
$590K Sell
81,044
-4,961
-6% -$34.1K 0.01% 1201
2017
Q4
$556K Buy
86,005
+15,852
+23% +$101K 0.01% 1258
2017
Q3
$462K Buy
70,153
+10,335
+17% +$64K 0.01% 1258
2017
Q2
$330K Sell
59,818
-34,860
-37% -$199K 0.01% 1410
2017
Q1
$546K Buy
94,678
+23,198
+32% +$127K 0.01% 1021
2016
Q4
$351K Buy
71,480
+22,310
+45% +$120K 0.01% 1208
2016
Q3
$299K Buy
49,170
+32,952
+203% +$197K 0.01% 1270
2016
Q2
$93K Buy
+16,218
New +$87.1K ﹤0.01% 1972

Other funds holding ABEV

Advisor Group's ABEV Position: Q4 2019 in Review

Advisor Group reduced its Ambev (ABEV) stake by 5.7% in Q4 2019, selling an estimated $14.5K and leaving 54,645 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #2197.

Advisor Group first reported a position in ABEV in Q2 2016 and has held it in 15 quarters since. The position peaked at $590K in Q1 2018. 304 funds tracked by Wall St. Rank hold ABEV as of Q4 2019.

  • Advisor Group held 54,645 shares of Ambev worth $255K as of Q4 2019.
  • Advisor Group sold 3,273 Ambev shares in Q4 2019, an estimated $14.5K.
  • Ambev made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2197 holding.
  • Advisor Group first reported a position in Ambev in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Ambev position peaked at $590K in Q1 2018.
  • 304 funds tracked by Wall St. Rank held Ambev as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.